Abionyx Pharma SA (ABNX) — Working Capital to Net Assets Ratio
Abionyx Pharma SA (ABNX) has a Working Capital to Net Assets ratio of 28.9% as of June 2025. Working capital of €1.57 Million (current assets of €5.45 Million minus current liabilities of €3.88 Million) is measured against net assets of €5.41 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ABNX defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Abionyx Pharma SA Working Capital to Net Assets (2013–2024)
This chart shows how Abionyx Pharma SA's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of June 2025, the ratio stands at 28.9%, reflecting working capital of €1.57 Million against net assets of €5.41 Million EUR. For the complete balance sheet picture, see total assets of Abionyx Pharma SA.
Annual Working Capital to Net Assets for Abionyx Pharma SA (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Abionyx Pharma SA from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Abionyx Pharma SA to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 29.0% | €2.15 Million | €7.42 Million | €5.86 Million | €3.71 Million | ▼ -8.4 pp |
| 2023 | 37.4% | €2.96 Million | €7.92 Million | €6.89 Million | €3.92 Million | ▲ +2.8 pp |
| 2022 | 34.6% | €2.48 Million | €7.17 Million | €7.57 Million | €5.09 Million | ▼ -24.1 pp |
| 2021 | 58.7% | €6.26 Million | €10.68 Million | €13.01 Million | €6.75 Million | ▼ -38.4 pp |
| 2020 | 97.1% | €6.43 Million | €6.63 Million | €10.03 Million | €3.60 Million | ▼ -2.8 pp |
| 2019 | 99.9% | €6.66 Million | €6.67 Million | €10.12 Million | €3.47 Million | ▼ -11.5 pp |
| 2018 | 111.4% | €4.27 Million | €3.84 Million | €12.78 Million | €8.51 Million | ▼ -53.3 pp |
| 2017 | 164.6% | €14.63 Million | €8.89 Million | €17.87 Million | €3.24 Million | ▲ +13.8 pp |
| 2016 | 150.8% | €22.03 Million | €14.61 Million | €28.72 Million | €6.69 Million | ▲ +30.7 pp |
| 2015 | 120.1% | €39.87 Million | €33.20 Million | €45.66 Million | €5.79 Million | ▼ -50404.9 pp |
| 2014 | 50525.0% | €6.06 Million | €12.00K | €10.76 Million | €4.70 Million | ▲ +50351.7 pp |
| 2013 | 173.3% | €10.68 Million | €6.16 Million | €13.76 Million | €3.08 Million | — |